Teliom-AH & Ciliom Tablets – Triple Therapy & Cilnidipine for Hypertension & Ang

The Teliom-AH & Ciliom Range is designed for patients requiring advanced cardiovascular management beyond standard therapies.

Teliom-AH combines Telmisartan, Amlodipine, and Hydrochlorothiazide to provide triple-action blood pressure control, making it ideal for high-risk patients with uncontrolled hypertension.

Ciliom (Cilnidipine) offers effective blood pressure control with added benefits in angina and improved tolerability, particularly by reducing sympathetic overactivity and minimizing reflex tachycardia.

Together, this range ensures comprehensive cardiovascular care, improved blood pressure management, and better long-term outcomes in complex patients.

🔹 Key Benefits

• Triple and targeted combination therapy for advanced cases
• Effective in high-risk and uncontrolled hypertension
• Supports renal protection and cardiovascular safety
• Improves BP control with better tolerability
• Helps reduce complications in long-term hypertension
• Suitable for angina with hypertension

🔹 Indications

• Uncontrolled hypertension
• High-risk cardiovascular patients
• Hypertension with angina
• Resistant hypertension
• Patients requiring multi-drug therapy

🔹 Composition

Teliom-AH

• Telmisartan 40 mg
• Amlodipine 5 mg
• Hydrochlorothiazide 12.5 mg

Ciliom

• Cilnidipine 10 mg / 20 mg